- Home
- GNS vs KRRO Comparison
GNS vs KRRO Comparison
Compare GNS & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNS
- KRRO
- Stock Information
- Founded
- GNS 2002
- KRRO 2014
- Country
- GNS Singapore
- KRRO United States
- Employees
- GNS N/A
- KRRO N/A
- Industry
- GNS Other Consumer Services
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- GNS Real Estate
- KRRO Health Care
- Exchange
- GNS Nasdaq
- KRRO Nasdaq
- Market Cap
- GNS 138.7M
- KRRO 125.4M
- IPO Year
- GNS 2022
- KRRO 2019
- Fundamental
- Price
- GNS $0.99
- KRRO $15.61
- Analyst Decision
- GNS
- KRRO Strong Buy
- Analyst Count
- GNS 0
- KRRO 7
- Target Price
- GNS N/A
- KRRO $85.67
- AVG Volume (30 Days)
- GNS 9.1M
- KRRO 120.6K
- Earning Date
- GNS 04-30-2025
- KRRO 08-12-2025
- Dividend Yield
- GNS N/A
- KRRO N/A
- EPS Growth
- GNS N/A
- KRRO N/A
- EPS
- GNS N/A
- KRRO N/A
- Revenue
- GNS $7,912,718.00
- KRRO $4,821,000.00
- Revenue This Year
- GNS $233.65
- KRRO $65.08
- Revenue Next Year
- GNS $570.20
- KRRO N/A
- P/E Ratio
- GNS N/A
- KRRO N/A
- Revenue Growth
- GNS N/A
- KRRO N/A
- 52 Week Low
- GNS $0.21
- KRRO $10.29
- 52 Week High
- GNS $2.37
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- GNS 45.02
- KRRO 58.63
- Support Level
- GNS $1.06
- KRRO $12.76
- Resistance Level
- GNS $1.26
- KRRO $17.82
- Average True Range (ATR)
- GNS 0.24
- KRRO 1.42
- MACD
- GNS -0.08
- KRRO 0.34
- Stochastic Oscillator
- GNS 5.56
- KRRO 58.36
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.